The new National Institutes of Health policy would strip research groups of hundreds of millions of dollars to cover so-called indirect expenses of studying Alzheimer’s, cancer, heart disease and a host of other illnesses — anything from clinical trials of new treatments to basic lab research that is the foundation for discoveries.

A federal judge in Massachusetts temporarily blocked the cuts from taking effect earlier this month in response to separate lawsuits filed by a group of 22 states plus organizations representing universities,

Long Island researchers and patients are urging the Trump administration to reconsider cuts to NIH research funding.

Healthcare organizations and 22 states have sued to stop the cuts. The case is expected to reach the Supreme Court.